Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19704174rdf:typepubmed:Citationlld:pubmed
pubmed-article:19704174lifeskim:mentionsumls-concept:C0019163lld:lifeskim
pubmed-article:19704174lifeskim:mentionsumls-concept:C0524909lld:lifeskim
pubmed-article:19704174lifeskim:mentionsumls-concept:C0050175lld:lifeskim
pubmed-article:19704174lifeskim:mentionsumls-concept:C0971023lld:lifeskim
pubmed-article:19704174pubmed:issue5lld:pubmed
pubmed-article:19704174pubmed:dateCreated2009-8-25lld:pubmed
pubmed-article:19704174pubmed:abstractTextThe efficacy of adefovir dipivoxil (ADV) or entecavir (ETV) rescue monotherapy has not been directly compared in hepatitis B e antigen (HBeAg)-positive patients with lamivudine (3TC)-resistant chronic hepatitis B (CHB). We compared the efficacy of ADV and ETV rescue monotherapy in HBeAg-positive patients with confirmed genotypic 3TC resistance.lld:pubmed
pubmed-article:19704174pubmed:languageenglld:pubmed
pubmed-article:19704174pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19704174pubmed:citationSubsetIMlld:pubmed
pubmed-article:19704174pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19704174pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19704174pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19704174pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19704174pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19704174pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19704174pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19704174pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19704174pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19704174pubmed:statusMEDLINElld:pubmed
pubmed-article:19704174pubmed:issn1359-6535lld:pubmed
pubmed-article:19704174pubmed:authorpubmed-author:AhnSang...lld:pubmed
pubmed-article:19704174pubmed:authorpubmed-author:HanKwang-Hyub...lld:pubmed
pubmed-article:19704174pubmed:authorpubmed-author:NguyenTinTlld:pubmed
pubmed-article:19704174pubmed:authorpubmed-author:ChonChae...lld:pubmed
pubmed-article:19704174pubmed:authorpubmed-author:KimHyung...lld:pubmed
pubmed-article:19704174pubmed:authorpubmed-author:LeeChun...lld:pubmed
pubmed-article:19704174pubmed:authorpubmed-author:KimDo...lld:pubmed
pubmed-article:19704174pubmed:authorpubmed-author:LeeKwan SikKSlld:pubmed
pubmed-article:19704174pubmed:authorpubmed-author:LeeJung MinJMlld:pubmed
pubmed-article:19704174pubmed:authorpubmed-author:PaikYong...lld:pubmed
pubmed-article:19704174pubmed:authorpubmed-author:ParkJun...lld:pubmed
pubmed-article:19704174pubmed:authorpubmed-author:KimJa KyungJKlld:pubmed
pubmed-article:19704174pubmed:authorpubmed-author:HongSun PyoSPlld:pubmed
pubmed-article:19704174pubmed:authorpubmed-author:LeeHyun...lld:pubmed
pubmed-article:19704174pubmed:issnTypePrintlld:pubmed
pubmed-article:19704174pubmed:volume14lld:pubmed
pubmed-article:19704174pubmed:ownerNLMlld:pubmed
pubmed-article:19704174pubmed:authorsCompleteYlld:pubmed
pubmed-article:19704174pubmed:pagination705-12lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:meshHeadingpubmed-meshheading:19704174...lld:pubmed
pubmed-article:19704174pubmed:year2009lld:pubmed
pubmed-article:19704174pubmed:articleTitleRescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir.lld:pubmed
pubmed-article:19704174pubmed:affiliationDepartment of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.lld:pubmed
pubmed-article:19704174pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19704174pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:19704174pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:19704174pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed